Finally, it is also worth mentioning that EZH2 gain-of-function mutations usually co-occur with BRAF V600E mutations in CM, promote aggressive cell morphologies and enhance melanoma tumor growth in vitro [126]. This evidence concerns the gene BRAF and melanoma.